EVOLENT HEALTH INC - A
EVHNYSETrading Snapshot
- Day Range
- $1,004.77 β $1,033.86
- 52-Week Range
- $2.10 β $8.98
- Volume
- $5.66B
- Avg Volume
- $5.83B
- Shares Outstanding
- 112.5M
- Next Earnings
- Nov 6, 2026
Fundamentals Snapshot
- Annual Revenue
- $1.88B
- Last Q Revenue
- $653M
- P/E Ratio
- -0.8
- P/S Ratio
- 0.2x
- EPS (TTM)
- $-4.49
- Dividend Yield
- 0.00%
- Dilution (1yr)
- β0.7%
Why Investors Own EVH
- βHigh-growth profile β revenue up +0.4% YoY with expanding US Equity exposure.
- βHealthy economics β 48% gross margin and 7% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
EVOLENT HEALTH INC - A
EVHAbout EVOLENT HEALTH INC - A
Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates
EVOLENT HEALTH INC - A tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift EVH price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
EVOLENT HEALTH INC - A announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.